A Cancer Research Associate is a key contributor in laboratories focused on understanding cancer’s causes, progression, and treatment. In this role, the associate assists in carrying out complex research projects by conducting experiments, analyzing data, and maintaining accurate lab records. Their work often includes preparing biological samples, culturing cancer cells, extracting DNA/RNA, and performing techniques such as PCR, Western blotting, and flow cytometry. These tasks support broader research goals, such as identifying genetic mutations, discovering biomarkers, or testing the efficacy of new drug candidates. Cancer Research Associates work closely with scientists, ensuring each step of the research process is performed with precision and aligned with project protocols.
Beyond benchwork, Cancer Research Associates also contribute to data management, help prepare findings for publication, and support regulatory compliance within the lab. In some cases, they may collaborate with clinical teams by processing patient-derived samples or tracking outcomes in clinical trials. Their ability to combine technical expertise with analytical thinking makes them indispensable in both academic and industry research settings. By supporting investigations into how cancer develops and responds to treatment, a Cancer Research Associate plays a vital role in accelerating the discovery of life-saving therapies and enhancing our understanding of one of the most complex diseases in medicine today.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China